Skeletal Effects of Sleeve Gastrectomy in Adolescents and Young Adults : A 2-Year Longitudinal Study
© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
CONTEXT: Vertical sleeve gastrectomy (VSG) is an increasingly common tool to achieve weight loss and improve metabolic health in adolescents and young adults with obesity, although it may adversely affect bone health.
OBJECTIVE: This work aimed to evaluate the effect of VSG on bone health in youth.
METHODS: An observational 2-year study was conducted at a tertiary care center of 66 patients aged 13 to 24 years with moderate-to-severe obesity meeting criteria for VSG. The patients underwent VSG (n = 30) or nonsurgical (n = 36) management per the decision of patient and clinical team. Main outcome measures included dual-energy x-ray absorptiometry (DXA) and high-resolution peripheral quantitative computed tomography (HRpQCT) measures of bone mineral density (BMD), geometry, and microarchitecture.
RESULTS: VSG patients achieved 25.3 ± 2.0% weight loss at 2 years (P < .001) while control subjects gained 4.0 ± 2.0% (P = .026). Total hip BMD declined 8.5 ± 1.0% following VSG compared with 0.1 ± 1.0% gain in controls (P < .001), with similar results at the femoral neck (P < .001). Total volumetric BMD (vBMD) decreased both at the distal radius and tibia following VSG (P < .001) driven primarily by trabecular vBMD loss (P < .001). Two-year changes in cortical vBMD did not differ between groups, though cortical porosity decreased following VSG both at the radius and tibia (P = .048 and P < .001). Cortical thickness increased in controls but not in VSG (P = .022 and P = .002 for between-group comparisons at the radius and tibia, respectively). Following VSG, estimated failure load decreased at the radius and did not demonstrate the physiologic increases at the tibia observed in controls.
CONCLUSION: VSG leads to progressive changes in bone health over 2 years, and may lead to increased skeletal fragility in adolescents and young adults.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:108 |
---|---|
Enthalten in: |
The Journal of clinical endocrinology and metabolism - 108(2023), 4 vom: 10. März, Seite 847-857 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mitchell, Deborah M [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bone metabolism |
---|
Anmerkungen: |
Date Completed 13.03.2023 Date Revised 27.12.2023 published: Print ClinicalTrials.gov: NCT02557438 Citation Status MEDLINE |
---|
doi: |
10.1210/clinem/dgac634 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM348287852 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM348287852 | ||
003 | DE-627 | ||
005 | 20231229123826.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1210/clinem/dgac634 |2 doi | |
028 | 5 | 2 | |a pubmed24n1240.xml |
035 | |a (DE-627)NLM348287852 | ||
035 | |a (NLM)36314507 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mitchell, Deborah M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Skeletal Effects of Sleeve Gastrectomy in Adolescents and Young Adults |b A 2-Year Longitudinal Study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.03.2023 | ||
500 | |a Date Revised 27.12.2023 | ||
500 | |a published: Print | ||
500 | |a ClinicalTrials.gov: NCT02557438 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
520 | |a CONTEXT: Vertical sleeve gastrectomy (VSG) is an increasingly common tool to achieve weight loss and improve metabolic health in adolescents and young adults with obesity, although it may adversely affect bone health | ||
520 | |a OBJECTIVE: This work aimed to evaluate the effect of VSG on bone health in youth | ||
520 | |a METHODS: An observational 2-year study was conducted at a tertiary care center of 66 patients aged 13 to 24 years with moderate-to-severe obesity meeting criteria for VSG. The patients underwent VSG (n = 30) or nonsurgical (n = 36) management per the decision of patient and clinical team. Main outcome measures included dual-energy x-ray absorptiometry (DXA) and high-resolution peripheral quantitative computed tomography (HRpQCT) measures of bone mineral density (BMD), geometry, and microarchitecture | ||
520 | |a RESULTS: VSG patients achieved 25.3 ± 2.0% weight loss at 2 years (P < .001) while control subjects gained 4.0 ± 2.0% (P = .026). Total hip BMD declined 8.5 ± 1.0% following VSG compared with 0.1 ± 1.0% gain in controls (P < .001), with similar results at the femoral neck (P < .001). Total volumetric BMD (vBMD) decreased both at the distal radius and tibia following VSG (P < .001) driven primarily by trabecular vBMD loss (P < .001). Two-year changes in cortical vBMD did not differ between groups, though cortical porosity decreased following VSG both at the radius and tibia (P = .048 and P < .001). Cortical thickness increased in controls but not in VSG (P = .022 and P = .002 for between-group comparisons at the radius and tibia, respectively). Following VSG, estimated failure load decreased at the radius and did not demonstrate the physiologic increases at the tibia observed in controls | ||
520 | |a CONCLUSION: VSG leads to progressive changes in bone health over 2 years, and may lead to increased skeletal fragility in adolescents and young adults | ||
650 | 4 | |a Observational Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a bone metabolism | |
650 | 4 | |a metabolic bariatric surgery | |
650 | 4 | |a obesity | |
650 | 4 | |a pediatric | |
700 | 1 | |a Singhal, Vibha |e verfasserin |4 aut | |
700 | 1 | |a Animashaun, Abisayo |e verfasserin |4 aut | |
700 | 1 | |a Bose, Amita |e verfasserin |4 aut | |
700 | 1 | |a Carmine, Brian |e verfasserin |4 aut | |
700 | 1 | |a Stanford, Fatima C |e verfasserin |4 aut | |
700 | 1 | |a Inge, Thomas H |e verfasserin |4 aut | |
700 | 1 | |a Kelsey, Megan M |e verfasserin |4 aut | |
700 | 1 | |a Lee, Hang |e verfasserin |4 aut | |
700 | 1 | |a Bouxsein, Mary L |e verfasserin |4 aut | |
700 | 1 | |a Yu, Elaine W |e verfasserin |4 aut | |
700 | 1 | |a Bredella, Miriam A |e verfasserin |4 aut | |
700 | 1 | |a Misra, Madhusmita |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of clinical endocrinology and metabolism |d 1945 |g 108(2023), 4 vom: 10. März, Seite 847-857 |w (DE-627)NLM00001821X |x 1945-7197 |7 nnns |
773 | 1 | 8 | |g volume:108 |g year:2023 |g number:4 |g day:10 |g month:03 |g pages:847-857 |
856 | 4 | 0 | |u http://dx.doi.org/10.1210/clinem/dgac634 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 108 |j 2023 |e 4 |b 10 |c 03 |h 847-857 |